Single-patent legislation hits another roadblock – Nature.com
“If the unitary patent is very expensive, we can predict nobody will use it except for large pharma companies,” he says. Justine Pila, who specializes in IP law at the University of Oxford, UK, agrees that large companies are most likely to find the ...
Subscribe to LegalLaw247.Com Newsletter
